Catherine Coste Biomerica Inc (BMRA) insider trading activity

BMRA Quotes by TradingView

Catherine Coste is Director of BIOMERICA INC. Currently has a direct ownership of 128,790 shares of BMRA, which is worth approximately $38,637. The most recent transaction as insider was on Dec 13, 2024, when has been sold 85,000 shares (Common Stock) at a price of $0.31 per share, resulting in proceeds of $26,350. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 129K
194.11% 3M change
194.11% 12M change
Total Value Held $38,637

Catherine Coste Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 13 2024
BUY
Grant, award, or other acquisition
$26,350 $0.31 p/Share
85,000 Added 39.76%
128,790 Common Stock
Jan 26 2023
BUY
Open market or private purchase
$6,482 $2.96 p/Share
2,190 Added 4.76%
43,790 Common Stock

Also insider at

UTRS
MINERVA SURGICAL INC Healthcare
Director
RNLX
Renalytix plc Healthcare
Director
CC

Catherine Coste

Director
Irvine, CA

Track Institutional and Insider Activities on BMRA

Follow BIOMERICA INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BMRA shares.

Notify only if

Insider Trading

Get notified when an Biomerica Inc insider buys or sells BMRA shares.

Notify only if

News

Receive news related to BIOMERICA INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BMRA